α-Pyrrolidinobutiophenone

α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s[2] which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.

α-Pyrrolidinobutiophenone
Legal status
Legal status
Identifiers
  • (RS)-1-Phenyl-2-(1-pyrrolidinyl)-1-butanone
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19NO
Molar mass217.312 g·mol−1
3D model (JSmol)
  • C2CCCN2C(CC)C(=O)c1ccccc1
  • InChI=1S/C14H19NO/c1-2-13(15-10-6-7-11-15)14(16)12-8-4-3-5-9-12/h3-5,8-9,13H,2,6-7,10-11H2,1H3 ☒N
  • Key:GSESDIFGJCCBHN-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Legality

edit

In the United States, it is a Schedule I controlled substance.[3]

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.[4]

As of October 2015 α-PBP is a controlled substance in China.[5]

See also

edit

References

edit
  1. ^ "Lists of: Scheduling Actions, Controlled Substances, Regulated Chemicals" (PDF). U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. Archived from the original (PDF) on 17 April 2016. Retrieved 30 August 2014.
  2. ^ Ernst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970
  3. ^ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
  4. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 29 June 2015.
  5. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.